Therapeutic Articles

• Dabigatran etexilate: A novel oral direct thrombin inhibitor [PDF] (AJHP)
• Emerging anticoagulants for venous thromboembolism prevention [PDF] (AJHP)
• New Options in Anticoagulation for Atrial Fibrillation (N Engl J Med)
• Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (N Engl J Med)
• Apixaban versus Warfarin in Patients with Atrial Fibrillation (N Engl J Med)
• Effect of Acetaminophen on International Normalized Ratio in Patients Receiving Warfarin Therapy (Pharmacotherapy)
• New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillation (AJHP)
• Improving the quality of care for patients at risk for venous thromboembolism (AJHP)
• Issues in assessing and reducing the risk for venous thromboembolism (AJHP)
• Emerging anticoagulants for venous thromboembolism prevention (AJHP)
• Weight-based heparin protocol using antifactor Xa monitoring (AJHP)
• Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation (Arch Intern Med) 2010;170:1433-1441
• Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism   (N Engl J Med)
• Dabigatran versus Warfarin in Patients with Atrial Fibrillation  (N Engl J Med)
• Warholak International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic (AJHP)
• Rivaroxaban: An oral direct inhibitor of factor Xa (AJHP)
• Challenges in managing venous thromboembolism and acute coronary syndrome: Case studies of the use of antithrombotic and antiplatelet therapies [PDF] (AJHP)
• Improving the quality of care for venous thromboembolism and acute coronary syndrome: Using evidence-based guidelines and performance measures [PDF] (AJHP)
•  Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: A case-based approach (Ann Pharmacother)

Practice Management Articles

• A New Era for Anticoagulation in Atrial Fibrillation (N Engl J Med)
• A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study (J Am Coll Cardiol)
• Effect of Chronic Kidney Disease on Warfarin Management in a Pharmacist-Managed Anticoagulation Clinic [PDF] (JMCP)
• International Normalized Ratio values in group versus individual appointment in a pharmacist-managed anticoagulation clinic [PDF] (AJHP)
• Anticoagulation therapy for hospitalized patients: Patterns of use, compliance with national guidelines and performance on quality measures [PDF] (AJHP)
• Development and implementation of pharmacist-managed inpatient anticoagulation monitoring program [PDF] (AJHP)
• Impact of health disparities on staff workload in pharmacist-managed anticoagulation clinics [PDF] (AJHP)
• Clinical and management challenges in preventing venous thromboembolism in health systems: a case-based panel discussion (AJHP)
• Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: A meta-analysis (AJHP)
• Implementation of a multidisciplinary, pharmacy-led, thromboprophylaxis program in total-joint arthroplasty patients (AJHP)
• Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital (AJHP)
• Initial management of deep venous thrombosis in the outpatient setting (AJHP)
• Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs medical centers: An update (AJHP)
• Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum (Ann Pharmacother)
• Advanced practice programs in hospital pharmacy: anticoagulation management [PDF]  (Hospital Pharmacy)
• The Kaiser Permanente Colorado clinical pharmacy anticoagulation service as a model of modern anticoagulant care (Thromb Res)
• Impact of an inpatient anticoagulation management service on clinical outcomes   (Ann Pharmacother)
• Implementation of pharmacy services in a telemedicine intensive care unit (AJHP)
• Applying quality measures and guidelines in the management of acute coronary syndrome and venous thromboembolism   (J Manag Care Pharm)
• Survey of hospitals for guidelines, policies, and protocols for anticoagulants (AJHP)
• Implementing anticoagulation management by pharmacists in the inpatient setting (AJHP)
• Outcomes of oral anticoagulant therapy managed by telephone versus in-office visits in an anticoagulation clinic setting (Chest)
• Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy (Chest)
• Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions   (Pharmacotherapy)
• Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service  (Ann Pharmacother)

Books

• Anticoagulation Therapy: A Point of Care Guide − William E. Dager, Michael P. Gulseth, Edith A. Nutescu
• Managing Anticoagulation Patients in the Hospital − Michael Gulseth
  Key Chapters:
  • Chapter 2: Literature Review Supporting Inpatient Pharmacy Management of Anticoagulation Service
  • Chapter 4: Planning of the Inpatient Anticoagulation Service
  • Chapter 6: Justifying the Program to Hospital Administration: The Financial Perspective
• Managing Oral Anticoagulation Therapy: Clinical and Operational Guidelines − Jack E Ansell, Lynn B. Oertel, Ann K. Wittkowsky